BioNexus Gene Lab Corp (BGLC)
0.442
-0.04
(-7.72%)
USD |
NASDAQ |
Jun 14, 16:00
0.44
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab EPS Diluted (TTM): -0.1818 for March 31, 2024
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -0.1818 |
December 31, 2023 | -0.1708 |
September 30, 2023 | -0.2126 |
June 30, 2023 | -0.0624 |
March 31, 2023 | -0.0542 |
December 31, 2022 | -0.046 |
September 30, 2022 | -0.0122 |
June 30, 2022 | 0.0139 |
March 31, 2022 | 0.0255 |
Date | Value |
---|---|
December 31, 2021 | 0.0363 |
September 30, 2021 | 0.0305 |
June 30, 2021 | 0.0372 |
March 31, 2021 | 0.0311 |
December 31, 2020 | 0.144 |
September 30, 2020 | 0.1373 |
June 30, 2020 | 0.1074 |
March 31, 2020 | 0.1033 |
December 31, 2019 | -0.0288 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-0.2126
Minimum
Sep 2023
0.144
Maximum
Dec 2020
-0.0057
Average
0.0197
Median
EPS Diluted (TTM) Benchmarks
Balchem Corp | 3.54 |
Friedman Industries Inc | 2.39 |
Solitario Resources Corp | -0.06 |
Golden Minerals Co | -1.002 |
Paramount Gold Nevada Corp | -0.13 |